loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202971 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Opocrin SpA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 OTSUKA PHARM CO LTD (4)

    filter

    01 FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (4)

    filter

    01 RX (4)

    filter

    01 ABILIFY MAINTENA KIT (4)

    filter

    01 Yes (4)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Italy
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      ARIPIPRAZOLE

      PDF Supplier PDF
      URL Supplier Web Content
      FOR SUSPENSION, EX...
      400MG
      2014-09-29
      202971
      ABILIFY MAINTENA K...
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag Italy
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        ARIPIPRAZOLE

        PDF Supplier PDF
        URL Supplier Web Content
        FOR SUSPENSION, EX...
        400MG/VIAL
        2013-02-28
        202971
        ABILIFY MAINTENA K...
        RX
        Yes
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag Italy
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          ARIPIPRAZOLE

          PDF Supplier PDF
          URL Supplier Web Content
          FOR SUSPENSION, EX...
          300MG
          2014-09-29
          202971
          ABILIFY MAINTENA K...
          RX
          Yes
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag Italy
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            ARIPIPRAZOLE

            PDF Supplier PDF
            URL Supplier Web Content
            FOR SUSPENSION, EX...
            300MG/VIAL
            2013-02-28
            202971
            ABILIFY MAINTENA K...
            RX
            Yes
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            Looking for FDA Orange Book APPLICATION 202971

            Looking for FDA Orange Book APPLICATION 202971 4

            19

            Opocrin SpA, based in Italy, is a pharmaceutical company.

            One of their notable products is ARIPIPRAZOLE, with a corresponding application number 202971.

            Regulatory Information RX

            With a dosage strength 400MG

            Dosage Form Route FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

            Reference Listed Drug Yes

            Approved since 2014-09-29

            18

            Opocrin SpA, based in Italy, is a pharmaceutical company.

            One of their notable products is ARIPIPRAZOLE, with a corresponding application number 202971.

            Regulatory Information RX

            With a dosage strength 400MG/VIAL

            Dosage Form Route FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

            Reference Listed Drug Yes

            Approved since 2013-02-28

            17

            Opocrin SpA, based in Italy, is a pharmaceutical company.

            One of their notable products is ARIPIPRAZOLE, with a corresponding application number 202971.

            Regulatory Information RX

            With a dosage strength 300MG

            Dosage Form Route FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

            Reference Listed Drug Yes

            Approved since 2014-09-29

            16

            Opocrin SpA, based in Italy, is a pharmaceutical company.

            One of their notable products is ARIPIPRAZOLE, with a corresponding application number 202971.

            Regulatory Information RX

            With a dosage strength 300MG/VIAL

            Dosage Form Route FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

            Reference Listed Drug Yes

            Approved since 2013-02-28

            Post Enquiry
            POST ENQUIRY